Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.

Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.

Item
http://www.wikidata.org/entity/Q33345866
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumorsThe safety and efficacy of cisplatin plus gemcitabine in recurrent ovarian cancer.Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer.Role of gemcitabine in cancer therapy.Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeuticsComplete remission of platinum-refractory primary Fallopian tube carcinoma with third-line gemcitabine plus cisplatin: A case report and review of the literature.Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry.Role of gemcitabine in the treatment of ovarian cancer.Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine.
P2860

Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.

Item
http://www.wikidata.org/entity/Q33345866
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@ast
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@en
type
label
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@ast
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@en
prefLabel
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@ast
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Phase II trial of gemcitabine ...... apsed ovarian cancer patients.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921